Authors
Latest:
Optimizing MOAs of JAK Inhibitors in a 36-Year-Old Male With a History of Atopic DermatitisJayme Heim, MSN, FNP-BC, explores strategies for optimizing the mechanisms of action of topical JAK inhibitors in treating a 36-year-old male patient with a history of atopic dermatitis, highlighting the potential benefits and considerations of this therapeutic approach.
Latest:
Provider and Patient Considerations for Prurigo Nodularis TreatmentMelodie Young, MSN, A/GNP-C, discusses how clinical and practical considerations, such as disease severity, patient preferences, and comorbidities, should guide the selection of treatment for prurigo nodularis, and emphasizes the importance of educating patients about the role of systemic therapies, addressing their concerns, and improving awareness of available treatment options.
Latest:
Photodynamic Pearls and Best PracticesMonica Boen, MD, discusses how implementing proven photodynamic therapy techniques and adhering to best practices can significantly improve treatment outcomes and patient satisfaction.
Latest:
Dealing With Student Loan Debt: How to Budget for Repayment and Other Financial GoalsIn this month’s Finance & Practice Management column, we illustrate the importance of developing and maintaining a budget for physicians at all stages of their careers.
Latest:
Shaping the Future of Dermatology With Insights From AAD 2025 and BeyondExplore key takeaways from AAD 2025, rosacea insights, psoriasis updates, and expert interviews in the latest issue of Dermatology Times.
Latest:
Partner with Hair Stylists and Give Them the Knowledge to Spot Scalp ConcernsThe HEROES program wants to make it easier for stylists to recognize scalp conditions and advise their clients to seek medical help.
Latest:
Meena Julapalli, MD: Finding and Prioritizing Joy in the Pediatric Dermatology SpecialtyJulapalli discusses her SPD 2024 lecture, "Rediscovering Joy in our Lives and the Workplace," excitement for the future of pediatric dermatology, and more.
Latest:
Topical Skin Care Probiotics Made With New Technology Yield Numerous BenefitsThe benefits include more accurate bacteria cell counts, more efficacious strains, and improved shelf life compared to non-heat-treated probiotics.
Latest:
Evaluating Lifileucel and Pembrolizumab in Advanced MelanomaPeter Prieto, MD, MPH, shares details of the IOV-COM-202 trial.
Latest:
Reviewing 3 Key Lebrikizumab Abstracts From AAD 2025Anabela Cardoso, MD, discussed lebrikizumab’s efficacy in improving itch, skin pain, sleep disturbance, and long-term management in atopic dermatitis.
Latest:
Clinical Insights Into Challenging Atopic Dermatitis Cases: Part 3Robert Posnick, MD, hosted a Case-Based Roundtable discussion to review 2 challenging cases of atopic dermatitis involving hyperpigmentation and alopecia areata.
Latest:
Women with Psoriasis More Likely to Discontinue Biologics Than Men, Study FindsA recent study reveals that women with psoriasis are more likely to discontinue biologic treatments, including IL-17 and IL-23 inhibitors, due to adverse events and treatment dissatisfaction.
Latest:
SDPA Literature Review Session Shares Clinical PearlsThis special literature review yields a deeper understanding of issues like treating acne, nutraceuticals, and more.
Latest:
Five Financial Ratios to Watch to Track Your Practice’s Financial HealthThese ratios will help you determine the level of financial stability of your practice and help you make better decisions for your future.
Latest:
Nearly half of FDA-authorized AI tools may be ineffectiveResearchers stated the lack of reported clinical validation data raises concerns about their effectiveness and safety.
Latest:
Nonablative Lasers Offer a Gentle Approach to Healthy SkinIn honor of National Healthy Skin Month, it is the perfect time to encourage patients to integrate gentle laser treatments into their yearly routine to maintain healthy, radiant skin.
Latest:
Cutaneous Lupus Considerations with Joseph Merola, MD, MMScDiscover the evolving landscape of lupus treatment, from the importance of monitoring vitamin D levels to advancements in emerging therapies targeting type 1 interferon and plasmacytoid dendritic cells.
Latest:
Advances in HS treatment with Chris Sayed, MDUnlike previous therapies, bimekizumab has shown continued efficacy at 48 and 96 weeks, offering long-term benefits to HS patients.
Latest:
Treatment Switches and the Future of Hidradenitis Suppurativa ManagementPanelists discuss how identifying optimal timing for treatment switches and emerging therapeutic innovations are reshaping the management landscape for hidradenitis suppurativa, with the potential to improve long-term patient outcomes.
Latest:
Addressing Causes of Female Hair Loss and Exploring Preventative MeasuresThis expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.
Latest:
5 Ways to Negotiate the Best Physician Employment ContractThere are simple tools that can help us achieve the best employment contract.
Latest:
Breaking the High Tech/High Cost Connection to Support Better Health EquityHealth care costs continue to rise in this country. According to a study by the Peterson Center on Healthcare and the Kaiser Family Foundation, health care spending totaled $3.8 trillion in 2019, $11,582 per person.
Latest:
The Future of laBCC Treatment with Vishal Patel, MD, FAAD, FACMSTreatment decisions are increasingly guided by patient values, preferences, and quality-of-life considerations.
Latest:
Living With Pachyonychia Congenita: Patient Perspectives and ActivismThe PC Project provides patients with access to the International PC Research Registry for clinical help with their rare and painful skin condition.
Latest:
The Mainstream Patient: June 27This week's edition of the Mainstream Patients features stories about FDA's latest approval, abortion, and more.
Latest:
Finding “Positive Exposure”: Organization Promotes Diversity and Reframes BeautySession at the 2024 SDPA Annual Summer Dermatology Conference helps clinicians reframe beauty and empower patients.
